Pediatric Bladder Tumors: A Ten-Year Retrospective Analysis



      To present our experience in a single pediatric urology practice over a 10-year period with bladder tumors in the pediatric population in an effort to add to the relatively small amount of existing data. We hope to expand the community's knowledge of presentations, management and natural history of pediatric bladder tumors.


      We retrospectively queried our electronic medical records for International Classification of Diseases, Tenth Revision (ICD-10) and Current Procedural Terminology (CPT) codes relevant for bladder tumors. Patients with underlying bladder pathology, such as neurogenic bladder, history of bladder exstrophy, and history of bladder augmentation, were excluded.


      We identified 30 patients with bladder tumors from 2011 to 2021. There were 21 males and 9 females. Age at diagnosis ranged from 16 months to 19 years. Tumors identified were: 11 of various inflammatory subtypes; 4 papillomas; 4 rhabdomyosarcomas; 3 papillary urothelial neoplasms of low malignant potential and 8 of other types. Treatment included transurethral resection of bladder tumor, chemoradiation and laparoscopic partial cystectomy. Twenty nine patients had disease limited to the bladder and 1 had disease outside the bladder. Follow-up ranged from 2 weeks to 13 years (median 19 months). All patients had no evidence of disease at most recent follow-up.


      Pediatric bladder tumors range from aggressive rhabdomyosarcomas to more benign urothelial lesions. Fortunately, the latter type of tumor is the more prevalent lesion. Knowledge of the treatment options and natural history of these tumors will hopefully be of benefit to clinicians and parents alike.


      PUNLMP (Papillary Urothelial Neoplasm of Low Malignant Potential), RMS (Rhabdomyosarcoma), SEER (Surveillance, Epidemiology and End Results), ICD-10 (International Classification of Diseases, Tenth Revision), CPT (Current Procedural Terminology), TURBT (Transurethral Resection of Bladder Tumor)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Karatzas A
        • Tzortzis V.
        Lower urinary tract symptoms and bladder cancer in children: the hidden scenario.
        Urol Ann. 2019; 11: 102-104
        • Shelmerdine S
        • Lorenzo A
        • Gupta A
        • Chavhan G.
        Pearls and pitfalls in diagnosing pediatric urinary bladder masses.
        RadioGraphics. 2017; 37 (pp. 1872-1891): 6
        • Exelby PR
        • Ghavimi F
        • Jereb B
        Genitourinary rhabdomyosarcoma in children.
        J Pediatr Surg. 1979; 13: 746-752
        • Alanee S
        • Shukla AR.
        Bladder malignancies in children aged <18 years: results from the surveillance, epidemiology, and end results database.
        BJU Int. 2010; 106: 557-560 2009.09093.x
        • Blasco Casares FJ
        • Sacristán Sanfelipe J
        • Ibarz Servio L
        • Batalla Cadira JL
        • Ruiz Marcellán FJ.
        Características del leiomioma vesical en nuestro medio [Characteristics of bladder leiomyoma in our setting].
        Arch Esp Urol. 1995; 48: 987-990
        • Fine SW
        • Humphrey PA
        • Dehner LP
        • Amin MB
        • Epstein JI.
        Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.
        J Urol. 2005; 174: 1976-1980
        • Bujons A
        • Caffaratti J
        • Garat JM
        • Villavicencio H
        Long-term follow-up of transitional cell carcinoma of the bladder in childhood.
        J Pediatr Urol. 2014; 10 (ISSN 1477-5131): 167-170
        • Rezaee ME
        • Dunaway CM
        • Baker ML
        • Penna FJ
        • Chavez DR.
        Urothelial cell carcinoma of the bladder in pediatric patients: a systematic review and data analysis of the world literature.
        J Pediatr Urol. 2019; 15: 309-314
        • Babjuk M
        • Burger M
        • Capoun O
        • et al.
        European Association of Urology Guidelines on non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ).
        Eur Urol. 2022; 81: 75-94
        • Castagnetti M
        • Herbst KW
        • Esposito C.
        Current treatment of pediatric bladder and prostate rhabdomyosarcoma (bladder preserving vs. radical cystectomy).
        Curr Opin Urol. 2019; 29: 487-492
        • Saltzman AF
        • Cost NG
        Current treatment of pediatric bladder and prostate rhabdomyosarcoma.
        Curr Urol Rep. 2018; 19 (Published 2018 Feb 22): 11
        • Nishio H
        • Mizuno K
        • Kawase K
        • et al.
        Robot-assisted radical cystectomy for pediatric bladder rhabdomyosarcoma.
        J Endourol Case Rep. 2020; 6 (Published 2020 Dec 29): 461-464
        • Lopes RI
        • Mello MF
        • Lorenzo AJ.
        Recent advances in pediatric bladder malignancies [version 1; peer review: 2 approved].
        F1000Research. 2020; 9: 147
        • Emir S
        • Özdemir Sİ
        • Demir HA
        • et al.
        Pediatric bladder/prostate rhabdomyosarcoma: eight cases from a single center.
        Turk J Pediatr. 2016; 58: 254-258
        • Ferrer FA
        • Isakoff M
        • Koyle MA.
        Bladder/prostate rhabdomyosarcoma: past, present and future.
        J Urol. 2006; 176: 1283-1291
        • Li P
        • Zhou H
        • Cao H
        • et al.
        Robot-assisted laparoscopic management of bladder/prostate rhabdomyosarcoma in children: initial series and 1-year outcomes.
        J Endourol. 2021; 35: 1520-1525
        • Wu HY.
        The surgical management of paediatric bladder and prostate rhabdomyosarcoma.
        Arab J Urol. 2013; 11: 40-46
        • Schmidt A
        • Warmann SW
        • Eckert F
        • et al.
        The role of reconstructive surgery and brachytherapy in pediatric bladder/prostate rhabdomyosarcoma.
        J Urol. 2020; 204: 825-834
        • Chargari C
        • Martelli H
        • Guérin F
        • et al.
        Pulsed-dose rate brachytherapy for pediatric bladder prostate rhabdomyosarcoma: compliance and early clinical results.
        Radiother Oncol. 2017; 124: 285-290
        • Chargari C
        • Haie-Meder C
        • Guérin F
        • et al.
        Brachytherapy combined with surgery for conservative treatment of children with bladder neck and/or prostate rhabdomyosarcoma.
        Int J Radiat Oncol Biol Phys. 2017; 98: 352-359
        • Martelli H
        • Haie-Meder C
        • Branchereau S
        • et al.
        Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experience.
        J Pediatr Surg. 2009; 44: 190-196
        • Ozden E
        • Mercimek MN
        • Sarikaya S.
        Laparoscopic bladder-sparing approach in patients with prostatic rhabdomyosarcoma: a case series of two pediatric patients.
        Urol J. 2019; 17 (Published 2019 Jul 22): 525-527
        • Ozturk U
        • Goktug HN
        • Tuygun C
        • et al.
        Pediatric bladder rhabdomyosarcoma: report of organ sparing treatment of two cases.
        J Pediatr Urol. 2013; 9: e111-e113
        • Komasara L
        • Gołębiewski A
        • Anzelewicz S
        • Czauderna P
        A review on surgical techniques and organ sparing procedures in bladder/prostate rhabdomyosarcoma.
        Eur J Pediatr Surg. 2014; 24: 467-473
        • Komasara L
        • Stefanowicz J
        • Bryks-Laszkowska A
        • Gołębiewski A
        • Czauderna P.
        Reconstructive option after radical mutilating surgery in children with genitourinary rhabdomyosarcoma: when sparing the bladder is not an option.
        Int J Urol. 2016; 23: 679-685